Segall Bryant & Hamill LLC Reduces Holdings in AdaptHealth Corp. $AHCO

Segall Bryant & Hamill LLC lowered its position in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 11.4% in the first quarter, Holdings Channel reports. The institutional investor owned 3,478,592 shares of the company’s stock after selling 445,927 shares during the quarter. Segall Bryant & Hamill LLC’s holdings in AdaptHealth were worth $41,395,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in AHCO. Rockefeller Capital Management L.P. raised its position in shares of AdaptHealth by 433.0% during the 4th quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock valued at $26,000 after buying an additional 2,100 shares during the period. PNC Financial Services Group Inc. grew its position in AdaptHealth by 22.3% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock worth $70,000 after acquiring an additional 1,279 shares during the period. Assetmark Inc. grew its position in AdaptHealth by 54.8% in the first quarter. Assetmark Inc. now owns 6,952 shares of the company’s stock worth $83,000 after acquiring an additional 2,460 shares during the period. Tower Research Capital LLC TRC increased its stake in AdaptHealth by 318.0% during the second quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock worth $90,000 after acquiring an additional 7,297 shares during the last quarter. Finally, Tidal Investments LLC acquired a new stake in AdaptHealth during the second quarter worth $96,000. Hedge funds and other institutional investors own 82.67% of the company’s stock.

Insider Activity at AdaptHealth

In other news, insider Russell E. Schuster III sold 11,275 shares of AdaptHealth stock in a transaction on Monday, June 1st. The stock was sold at an average price of $10.06, for a total value of $113,426.50. Following the completion of the sale, the insider directly owned 136,538 shares of the company’s stock, valued at approximately $1,373,572.28. The trade was a 7.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.95% of the stock is currently owned by corporate insiders.

AdaptHealth Stock Up 1.1%

Shares of NASDAQ AHCO opened at $10.80 on Friday. The firm has a market cap of $1.47 billion, a price-to-earnings ratio of -17.42, a PEG ratio of 0.54 and a beta of 1.45. The company has a quick ratio of 0.71, a current ratio of 0.92 and a debt-to-equity ratio of 1.21. AdaptHealth Corp. has a 52-week low of $8.51 and a 52-week high of $13.43. The business’s 50 day moving average is $10.28 and its two-hundred day moving average is $10.68.

Analysts Set New Price Targets

Several brokerages have recently commented on AHCO. Robert W. Baird decreased their price target on AdaptHealth from $18.00 to $15.00 and set an “outperform” rating on the stock in a research note on Monday, July 6th. Wall Street Zen raised AdaptHealth from a “hold” rating to a “buy” rating in a research report on Sunday, June 14th. UBS Group reduced their price objective on shares of AdaptHealth from $15.00 to $14.00 and set a “buy” rating on the stock in a report on Wednesday, May 6th. Truist Financial boosted their price objective on shares of AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a report on Monday, April 13th. Finally, Jefferies Financial Group raised shares of AdaptHealth from a “hold” rating to a “buy” rating and upped their target price for the company from $11.00 to $13.00 in a research report on Tuesday, July 21st. Seven research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $14.14.

AdaptHealth Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.